| Regulatory Classification and Intended Use | The container may be a medical device, a component of a sterile barrier system, or packaging for a bone graft product. The regulatory pathway depends on its intended use, contact with the contents, and sterility claims. | Applicable Chinese medical device regulations; destination-market requirements; ISO 14971 for risk management. | Product intended-use statement, regulatory classification rationale, technical specifications, and market-specific compliance plan. | The manufacturer clearly defines the product scope, use environment, contact conditions, and responsibility for final product registration. | Critical |
| Quality Management System | A controlled quality system helps ensure consistent production, traceability, document control, corrective action, and change management. | ISO 13485:2016; applicable Chinese Good Manufacturing Practice requirements for medical devices. | Valid quality certificate, certification scope, recent audit records, quality manual, complaint procedure, and corrective-action records. | The certificate covers the relevant product category and manufacturing site, not only an unrelated product line or trading office. | Critical |
| Material Safety and Biocompatibility | Materials that contact bone graft material, tissue, or medicinal contents must be assessed for biological risks, chemical leachables, and residues. | ISO 10993-1; applicable parts of the ISO 10993 series; USP or pharmacopoeial requirements where applicable. | Material composition, supplier declarations, biocompatibility evaluation, extractables and leachables assessment, and material-change history. | Materials are fully identified, controlled by specification, suitable for the intended contact duration, and supported by risk-based biological evaluation. | Critical |
| Sterile Barrier System Performance | If the container is supplied sterile, the packaging must maintain sterility until the stated expiry date and remain suitable for transport and handling. | ISO 11607-1 for materials and sterile barrier systems; ISO 11607-2 for forming, sealing, and assembly processes. | Packaging validation protocol and report, seal-strength results, integrity testing, aging data, and distribution simulation results. | Validation covers the actual container configuration, sealing process, sterilization method, storage conditions, and distribution risks. | Critical |
| Sterilization Compatibility | Different materials respond differently to ethylene oxide, radiation, steam, or other sterilization processes. Incorrect selection can cause deformation, embrittlement, residues, or loss of barrier performance. | ISO 11135 for ethylene oxide; ISO 11137 for radiation; ISO 17665 for moist heat; ISO 11737 for bioburden and sterility testing, where applicable. | Validated sterilization method, material compatibility data, residual testing, dose or cycle records, and post-sterilization inspection results. | The proposed container is tested after the intended sterilization process rather than only in its unsterilized condition. | Critical |
| Container Closure Integrity | A reliable closure prevents leakage, contamination, moisture ingress, and loss of product during storage and shipment. | Applicable container-closure integrity methods; ASTM F2096, ASTM F2338, or other validated methods as appropriate to the design. | Leak-test method, detection limit, validation report, closure drawings, torque or sealing specifications, and routine inspection records. | The test method is suitable for the container geometry and demonstrates performance under normal, aged, and transport-stressed conditions. | Critical |
| Dimensional and Functional Accuracy | Accurate dimensions support compatibility with filling equipment, surgical handling, secondary packaging, and controlled delivery of bone filling material. | Approved product drawings; ISO 286 or equivalent dimensional-tolerance practices where relevant. | Technical drawings, critical dimensions, tolerance table, inspection gauges, capability data, and sample measurement reports. | Critical dimensions are defined, measured with calibrated equipment, and linked to functional requirements such as fit, opening, closure, and dispensing. | High |
| Mechanical Strength and Transport Durability | The container should resist cracking, deformation, puncture, and closure failure during filling, sterilization, handling, and distribution. | ISO 11607 distribution considerations; ASTM D4169 or ISTA distribution-testing practices, when applicable. | Compression, drop, vibration, impact, puncture, and post-transport integrity test reports. | Testing reflects the actual packaging configuration and includes inspection for damage, leakage, deformation, and loss of sterility assurance. | High |
| Chemical Compatibility and Product Stability | Contact with graft materials, preservatives, moisture, or sterilization residues may affect container properties or product quality. | ISO 10993 chemical characterization principles; ASTM F1980 for accelerated aging of sterile barrier systems, where applicable. | Compatibility study, extractables and leachables data, moisture-transmission data, and real-time or accelerated aging results. | Studies use the actual container, closure, contents, sterilization process, and intended storage conditions. | Critical |
| Cleanliness and Particulate Control | Particles, fibers, mold-release residues, and manufacturing contaminants can compromise the safety and usability of bone filling materials. | Applicable cleanroom and contamination-control requirements; ISO 14644 series for cleanroom classification where used. | Cleanroom classification, environmental-monitoring plan, particulate limits, cleaning procedures, gowning controls, and product bioburden results. | Cleanliness requirements are defined by risk assessment and verified through documented sampling and trend analysis. | High |
| Manufacturing Process Control | Injection molding, thermoforming, extrusion, assembly, and sealing parameters can directly affect wall thickness, closure performance, and sterility-barrier integrity. | ISO 13485 process controls; ISO 14971 risk-based control of critical manufacturing steps. | Process flow chart, work instructions, process-validation reports, in-process inspection records, and equipment-maintenance logs. | Critical parameters are identified, validated when necessary, monitored during production, and protected from unauthorized changes. | High |
| Traceability and Batch Control | Traceability allows rapid investigation of defects and supports effective recall or field action if a quality issue occurs. | ISO 13485 traceability and record-control requirements; applicable local regulations. | Lot-numbering procedure, raw-material records, production history, inspection records, sterilization records, and distribution records. | Each shipment can be linked to raw materials, tooling, production operators, inspection results, sterilization, and release approval. | Critical |
| Labeling and Packaging Information | Clear labeling supports correct handling, storage, identification, sterility status, and use within the customer’s validated process. | ISO 15223-1 for medical-device symbols; ISO 20417 for information supplied by the manufacturer; destination-market labeling rules. | Artwork control procedure, label samples, symbol justification, UDI or identification plan where applicable, and translation controls. | Labels identify product code, lot or batch, sterilization status, expiry information where applicable, storage conditions, and handling limitations. | High |
| Shelf-Life and Aging Validation | Packaging materials and closures can change over time, particularly after sterilization and exposure to temperature or humidity. | ASTM F1980 for accelerated aging; ISO 11607 for sterile barrier-system stability. | Real-time aging plan, accelerated-aging rationale, aged seal and integrity results, and expiry-date justification. | The claimed shelf life is supported by testing of the final packaged and sterilized configuration. | Critical |
| Supplier and Raw-Material Control | Consistent resin, elastomer, adhesive, and other component quality is necessary for repeatable container performance. | ISO 13485 purchasing and supplier-control requirements; applicable material specifications. | Approved-supplier list, incoming-inspection records, certificates of analysis, change-notification procedure, and supplier-audit evidence. | Critical materials have defined specifications, acceptance criteria, lot traceability, and formal notification before significant changes. | High |
| Design Transfer and Change Management | Changes to resin, mold, sealing equipment, sterilization, or production location can affect validated performance. | ISO 13485 design and development controls; ISO 14971 risk-management principles. | Design history records, engineering-change procedure, change-impact assessments, revalidation policy, and approval records. | The manufacturer evaluates whether changes require additional verification, validation, regulatory notification, or customer approval. | Critical |
| Testing Laboratory Competence | Reliable test results depend on appropriate methods, calibrated equipment, competent personnel, and controlled laboratory procedures. | ISO/IEC 17025 for testing-laboratory competence, where applicable. | Laboratory accreditation scope, test methods, equipment-calibration certificates, raw data, and independent laboratory reports. | Reports identify the tested configuration, method, sample size, acceptance criteria, deviations, and final conclusion. | High |
| Production Capacity and Delivery Reliability | Stable capacity reduces the risk of interruptions, uncontrolled outsourcing, and inconsistent quality during scale-up. | ISO 13485 resource-management and production-control requirements. | Capacity plan, validated equipment list, production lead-time data, business-continuity plan, and on-time-delivery records. | Capacity claims are supported by actual equipment, trained personnel, documented production planning, and contingency arrangements. | High |
| Technical Support and Documentation | Medical packaging projects often require support with specifications, validation, sampling, sterilization, and regulatory submissions. | ISO 13485 documentation and customer-communication requirements. | Technical file index, validation templates, drawing-control process, complaint-response procedure, and engineering-support contacts. | The manufacturer can provide controlled documents, clear technical responses, and timely support throughout qualification and production. | Medium |
| Total Cost of Ownership | The lowest unit price may not represent the lowest total cost after tooling, validation, sterilization, inspection, freight, rejected lots, and regulatory work are included. | Customer-specific purchasing and quality agreements; applicable regulatory requirements. | Itemized quotation, tooling ownership terms, sample and validation charges, minimum order quantity, packaging configuration, and change-cost policy. | Compare qualified cost, validation effort, delivery risk, defect risk, and long-term supply stability rather than unit price alone. | Medium |
| Environmental and Waste Considerations | Material selection, sterilization method, packaging volume, and disposal requirements can affect environmental impact and operating cost. | Applicable environmental regulations; ISO 14001 may be used to evaluate an environmental management system. | Material identification, recycling or disposal guidance, environmental permits where applicable, waste-reduction data, and environmental-management certificates. | Environmental claims are supported by documented material information and do not compromise sterility, biocompatibility, or required performance. | Medium |